Homology Medicines (NASDAQ: FIXX)
Some price data may be temporarily unavailable.
Homology Medicines Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Homology Medicines Company Info
Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA.
News & Analysis
Featured Article
Why Homology Medicines Stock Is Sinking Today
Dilution is on the way thanks to the company's latest stock offering.
Keith Speights | Apr 7, 2021
Featured Article
Codexis Is Chasing a Blockbuster Opportunity. Can It Compete With Gene Therapies?
The company is developing a novel enzyme-based treatment for phenylketonuria (PKU), but it faces growing competition from potentially curative gene therapies.
Maxx Chatsko | Jan 28, 2020
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.